Glaukos (GKOS) Non-Current Debt (2014 - 2015)
Glaukos' (GKOS) quarterly Non-Current Debt came in at $765000.0 in Q4 2015, down 91.47% year-on-year from $9.0 million in Q4 2014, and down 74.83% on a QoQ basis from $3.0 million in Q3 2015.
Glaukos (GKOS) Non-Current Debt (2014 - 2015) Analysis & Trends
Glaukos (GKOS) has 2 years of Non-Current Debt data on file, last reported at $765000.0 in Q4 2015.
- On a quarterly basis, Non-Current Debt fell 91.47% year-over-year to $765000.0 in Q4 2015; TTM through Dec 2015 was $765000.0, a 91.47% decrease from a year earlier, with the FY2015 full-year figure at $765000.0, down 91.47% from the prior year.
- Non-Current Debt for Q4 2015 stood at $765000.0, down from $3.0 million in the prior quarter.
- Over the last five years, Non-Current Debt for GKOS reached as high as $11.6 million in Q2 2015 and fell as low as $765000.0 in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.18 Bn |
| 10 | Glaukos | 8.83 Bn | 8.73 Bn | 117.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 765,000.00 |
| Sep 30, 2015 | 3.04 Mn |
| Jun 30, 2015 | 11.64 Mn |
| Dec 31, 2014 | 8.97 Mn |